CCEL CEO gave a virtual pitch today that generated some volume. Presentation is on their website and worth a look. Among other opportunities from recent Duke deal is the opening of an infusion clinic early next year that would generate $24 million in high margin annual revenues--a 70% increase from their current $33 million run rate.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.